Navigation Links
New Findings Reported by TJ Gan and Authors from Duke Anesthesiology Demonstrate Efficacy of Cheetah Medical's NICOM® Bioreactance® Technology to Guide Goal Directed Intraoperative Therapy
Date:10/17/2011

TEL-AVIV, Israel and VANCOUVER, Washington, October 17, 2011 /PRNewswire/ --

Results from a study validating Cheetah Medical's non-invasive NICOM system for use in surgery to guide fluid management were presented October 16 at the 2011 American Society of Anesthesiologists Annual Meeting in Chicago. This new study complements a strong body of evidence that demonstrates that when anesthesiologists base delivery of intravenous fluids on repetitive measurements of cardiac output, they are able to significantly reduce a host of complications associated with surgery and the length of hospital stay. This guided approach to deliver fluids is known as Goal Directed Therapy (GDT).

The Cheetah NICOM has been validated to provide highly accurate continuous hemodynamic information that can be reliably used to guide fluid management and support GDT. In this study, Duke Anesthesia researchers used Cheetah Medical's non-invasive NICOM® cardiac output & hemodynamic monitoring system alongside the invasive legacy transesophageal Doppler. Study investigators compared readings obtained with the legacy system to the NICOM in 61 patients as they underwent major surgery and found a consistent and significant correlation between both devices' readings and directions on fluid management. In addition, results indicated that the invasive Doppler device was twice as likely to fail to provide readings during the case for technical reasons as compared to the non-invasive NICOM.

"The results from this study add to a large body of evidence showing that perioperative Goal Directed Therapy using non-invasive hemodynamic monitors should be considered in patients undergoing major surgery or in high risk patients. This strategy improves patient outcomes and reduces length of hospital stay," said Tong J. Gan, MD Professor of Anesthesiology and Vice Chair for Clinical Research at Duke University Medical Center and the study's Principal Investigator. "A non-invasive hemodynamic monitor provides an option that could make monitoring simpler during surgery."

In addition to compelling clinical advantages to the patient, GDT has been shown to deliver marked cost reductions and efficiency improvements to the healthcare system. As a result, numerous healthcare authorities recommend adoption of GDT protocols, including the Centers for Medicare and Medicaid Services (CMS), the UK National Health Service (NHS), the Agency for Healthcare Research and Quality (AHRQ) and the National Institute for Health and Clinical Excellence (NICE). However, close to 20 years after the significant value of GDT protocols was established using Doppler probes which are inserted into the patient's esophagus, GDT is used in just a fraction of major surgical procedures. In a recent survey of hundreds of American and European anesthesiologists, more than 90% conveyed that their current operative fluid management could be improved[1]. The study found a considerable gap between evidence regarding the benefits of GDT and the clinical utilization of invasive technologies that limit practical implementation.

"We are pleased with the Duke study findings and hope they will encourage use of Cheetah's NICOM system in providing GDT to advance the quality of care for significantly more patients who are not benefiting from these approaches today," said Yoav Avidor, MD, CEO of Cheetah Medical. "Further, we believe that our technology may better enable hospitals to deal with the rising costs of treating certain surgical complications that can be mitigated with GDT and empower standardization as more clinicians deliver this state of the art clinical practice."

About Cheetah Medical

Cheetah Medical's NICOM® Noninvasive Cardiac Output and Hemodynamic Monitoring System uses the company's proprietary BIOREACTANCE® Technology to deliver continuous, accurate, noninvasive cardiac output (CO) and other vital hemodynamic monitoring parameters, useful for fluid management and drug titration. The system is US FDA cleared and CE Marked, and since its commercial launch in 2008 has been adopted by a growing number of clinicians worldwide. Cheetah Medical headquarters is located in Tel-Aviv, Israel and its United States headquarters is located in Vancouver, Washington. For more information, visit our website at http://www.cheetah-medical.com.

  1. Cannesson M, Pestel G, Ricks C, et al. Hemodynamic monitoring and management in patients undergoing high risk surgery: a survey among North American and European anesthesiologists. Critical Care, 2011;15(4):R197.

For further information contact:
Paul Kidwell
paulkidwell@comcast.net
+1-617-680-1088



'/>"/>
SOURCE Cheetah Medical Ltd
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Otonomy Presents Positive New Findings From Phase 1b Study of OTO-104 in Menieres Disease at International Conference
2. The Human Brain is Sensitive to Light, Breakthrough Findings From Valkee and the University of Oulu
3. Researchers From More Than 30 Countries Share Findings About the Use of Ultrasound in the Prevention, Diagnosis and Treatment of Heart Disease
4. New findings by UCR scientists hold big promise for fight against mosquito-borne diseases
5. Ceregene Reports New Findings Regarding How Parkinsons Brains Respond to Neurotrophic Factors
6. Microplasmin Meets Primary Endpoint in Second Phase III Trial in VMA, Confirms Positive Findings of First Trial
7. New findings promising for transformation optics, cloaking
8. Findings show promise for nuclear fusion test reactors
9. No New Findings in Atrazine Study Promoted by Discredited Researcher, According to the Hudson Institute Center for Global Food Issues
10. Independent Forensics Company DNalysis Implement Amphora's PatentSafe Solution to Preserve and Secure Findings
11. Promega and SwitchGear Publish Findings from Combined Technologies that Correlate Binding Events and Transcriptional Activity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , ... June 27, 2016 , ... ... for Amgen, will join the faculty of the University of North Carolina ... professor of strategy and entrepreneurship at UNC Kenan-Flagler, with a focus on the ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... ... June 23, 2016 , ... UAS LifeSciences, one of the ... brand, UP4™ Probiotics, into Target stores nationwide. The company, which has been manufacturing ... to its list of well-respected retailers. This list includes such fine stores as ...
(Date:6/23/2016)... 2016 Houston Methodist Willowbrook Hospital has ... Association to serve as their official health care ... Willowbrook will provide sponsorship support, athletic training services, ... coaches, volunteers, athletes and families. "We ... Association and to bring Houston Methodist quality services ...
Breaking Biology Technology:
(Date:6/3/2016)... LONDON , June 3, 2016 /PRNewswire/ ... Transport Management) von Nepal ... ,Angebot und Lieferung hochsicherer geprägter Kennzeichen, einschließlich ... weltweit führend in der Produktion und Implementierung ... an der Ausschreibung im Januar teilgenommen, aber ...
(Date:6/1/2016)... , June 1, 2016 Favorable ... Election Administration and Criminal Identification to Boost Global Biometrics ... recently released TechSci Research report, " Global Biometrics Market ... Competition Forecast and Opportunities, 2011 - 2021", the global ... by 2021, on account of growing security concerns across ...
(Date:5/12/2016)... 2016 WearablesResearch.com , a brand of ... results from the Q1 wave of its quarterly wearables ... consumers, receptivity to a program where they would receive ... insurance company. "We were surprised to see ... Michael LaColla , CEO of Troubadour Research, "primarily because ...
Breaking Biology News(10 mins):